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1. Introduction 
We have shown that the two major endogenous 
opioid peptides, methionine-enkephalin and leucine- 
enkephalin [ 1,2] (enkephalin [Met’] and enkephalin- 
[Leu’]) rapidly react with acetaldehyde in aqueous 
buffers to give a stable ‘acetaldehyde-enkephalin’ 
adduct, referred to as ‘acetaldehyde-enkephalin[Met’]’ 
and ‘acetaldehyde-enkephalin [Leu’]‘, respectively. 
The structure of these adducts was established as a 
diastereoisomeric mixture of the (2R, 5S)- and (2S, 
5S)-2-methylimidazolidin-4-one derivatives of the 
parent peptides in which the acetaldehyde moiety 
forms a molecular bridge between the amide nitrogen 
of the Tyr(‘)-Gly(‘) peptide bond and the o-NH, of 
the N-terminal Tyr residue [3]. This is shown in 
scheme 1. Here, we complement [3] by describing 
the influence that acetaldehyde adduct formation has 
on the intrinsic opiate activity of enkephalin [Met’] 
and enkephalin [Leu’]. 
(ZR.55)- ‘3 (25,5S)- “ 
occtoldehyde adduct 
methlonl”e-enkepho,l”, I?. .G,y-L-PhQ_L_~,?,_~ 
leucme-mkephalm, R= -Gly-L-F+w-L-Lw-On Scheme 1 
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2. Materials and methods 
Enkephalin[Met’] and enkephalin [Leu’] were 
obtained from Miles Labs. The corresponding acetal- 
dehyde adducts were prepared as in [3]. [3H]- 
Enkephalin [D-Ala’, D-Leu’] (52 Ci/mmol) was from 
the Radiochemical Centre, Amersham and [3H]dihy- 
dromorphine (47 Ci/mmol) was from New England 
Nuclear Corp. Boston, MA. Bacitracin was obtained 
from Sigma Chemical Co. Naloxone hydrochloride 
was a gift from Endo Labs., NY and morphine sulphate 
was kindly provided by St Mary’s Hospital Pharmacy. 
2.1. Opiate receptor binding assay 
Brain membranes from male Sprague-Dawley rats 
were prepared as in [4]. Aliquots of this preparation 
in 2.0 ml final vol. were incubated with either tritiated 
enkephalin (1.2 nm) or dihydromorphine (1.05 nm) 
and different concentrations of test substance at 0°C 
(ice/water mixture) for 2 h in the presence of baci- 
tracin, 0.1 mg/ml. The incubation solutions were 
filtered on Whatman GF/B glass fibre filters, under 
vacuum, and washed with 2 X 4 ml ice-cold incuba- 
tion buffer (Tris-HCl buffer, 50 mM, pH 7.4). Radio- 
activity was determined by scintillation counting using 
a Packard 3255 scintillation spectrometer. Non-specific 
binding was determined by incubations in the presence 
and absence of a large excess ( 10m6 M) of unlabelled 
enkephalin [Met’] or naloxone. Assays were performed 
in triplicate at 6 or 7 concentrations of test substance, 
and the ICso values obtained by graphical methods. 
2.2. Mouse vas deferens and guinea pig ileum 
Field stimulation of the isolated mouse vas def- 
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erens was done as in [S]. Test substances were added 
to the tissue preparation which was incubated in 
2.0 ml Mg-free Krebs buffer solution and gassed with 
5% CO* in 02. Supramaximal coaxial stimulation 
of the guinea pig ileum [6,7] was done using a 
30 ml organ bath gassed with 5% COP in O2 at 37°C. 
Respective tissues were stimulated using a Grass 
S-44 stimulator, and the resultant contractions trans- 
duced with a Grass FT-03 transducer. The transduced 
contractions were recorded with a Grass model 7C 
polygraph pen recorder. Dose-response curves were 
constructed from duplicate assays at 5 or 6 concen- 
trations of each substance using at least 4 different 
tissue preparations. The results shown are the mean 
values obtained from these experiments. 
3. Results and discussion 
Whereas both enkephalin [Met’] and enkephalin- 
[Leu’] have potent agonist activity as shown by their 
ability to inhibit electrically evoked contractions of 
the isolated mouse vas deferens and the guinea pig 
ileum [I], the obverse is true for their respective acet- 
aldehyde adducts (table 1; for comparison, data for 
morphine and NCY-ethyl-enkephalin [Met’] are 
included). Enkephalin[Met’] is -300-times more 
active than its acetaldehyde adduct in the mouse vas 
deferens, and loo-times as potent in the ileum assay. 
Similarly, enkephalin[Leu’] is -550- and 70-times 
more active than its acetaldehyde derivative in the vas 
deferens and ileum, respectively. Therefore, in these 
two assay systems, acetaldehyde adduct formation 
causes a pronounced loss in activity when compared 
to the parent pentapeptides. For ‘acetaldehyde- 
enkephalin [Met’]’ it appears that the observed fall in 
potency can be largely, but not exclusively, ascribed 
to alkylationofthea-NH, because iV&-ethylenkephalin- 
[Met’] also displays greatly reduced activity. Presum- 
ably, ring formation also severely restricts the con- 
formational mobility of the N-terminal region of the 
peptide; note [8,9] in which indicate that the relative 
flexibility of this region of the enkephalin molecule 
may be important in receptor binding. 
The activity trend outlined above is similarly 
evinced by measuring opiate receptor binding in a 
particulate fraction from rat brain (table 2). Enke- 
phalin[Met’] is -850-times and enkephalin [Leu’] 
300-times more potent than their acetaldehyde deriv- 
atives in inhibiting [3H]enkephalin[D-Ala2, D-Leu’] 
binding. The inhibitory effect of the ‘acetaldehyde- 
enkephalind on [3H]dihydromorphine binding is 
negligible. These results have been obtained with a 
diastereoisomeric mixture of the acetaldehyde adducts, 
and although the intrinsic activity of each mixture is 
very low it is conceivable that the individual isomers 
have differential activities depending on the opiate 
assay used; a solution to this particular conundrum 
must await the separation of each diastereoisomer. 
The binding data also show that acetaldehyde adduct 
formation leads to a loss of binding to both &-receptors 
and p-receptors [lo-121. 
The investigation of the intrinsic biological activity 
of these adducts is limited by their temperature- 
dependent decomposition to give the parent peptide 
and acetaldehyde [4]. Because ‘acetaldehyde-enke- 
phalins’ are markedly less active than their precursor 
pentapeptides any fractional decomposition will give 
abnormally high apparent biological potencies. There- 
fore, each investigation should begin with newly syn- 
Table 1 
Inhibition of electrically induced contractions of the isolated mouse vas deferens 
and the guinea pig ileum by morphine and enkephalin derivatives 
Test substance IC,, (morphine) / ZC,, (peptide) 
Vas deferens Ileum 
Morphinea 1.0 1.0 
Enkephalin[Met’] 35.70 0.75 
Acetaldehyde-enkephalin[Met5] 0.12 0.008 
Enkephalin[LeuS] 39.20 0.24 
Acetaldehyde-enkephalin[Leu’] 0.07 0.0036 
No-Ethylenkephalin[Met’] 0.31 0.05 
a The mean ICI’,, value for morphine was 500 and 73 nm for the mouse vas def- 
erens and the guinea pig ileum, respectively 
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Table 2 
Comparison of the displacement of [aH]enkephalin[D-Ala’, D-Leu’] and 
[ ‘Hldihydromorphine binding from brain membranes by morphine and enkephalin 
derivatives 
April 1980 
Unlabelled compound IC,, (morphine) / ZC,, (peptide) 
[ 3H]enkephalin- [‘Hldihydro- 
[D-AlaZ, D-LeuS] morphine 
Morphinea 1.0 1.0 
Enkephalm[Met’ ] 10.4 0.58 
Acetaldehyde-enkephalin[ Met’] 0.012 0.0005 
Enkephalin [Leu5] 5.5 0.54 
Acetaldehyde-enkephalin[ LeuS] 0.018 0.0005 
A’“-Ethylenkephalin[Mets] 0.92 0.0006 
a The mean IC,, value for morphine was 46 and 2.9 nm for the inhibition of [‘HI- 
enkephalin[D-Ala2, D-LeuS] and [3H]dihydromorphine binding, respectively 
thesised material; the consequences of acetaldehyde 
adduct breakdown should be considered in all further 
studies. 
Chemical studies indicate that the critical ammo 
acid sequence necessary for rapid acetaldehyde adduct 
formation is Tyr-Gly-Gly- and this also holds for 
the largest opioid peptideD-endorphin, which similarly 
reacts with acetaldehyde and undergoes a change in 
opiate activity [4]. It seems very likely that all the 
larger opioid peptides with the enkephalin [Met’] 
N-terminal sequence [13,14] and a-neo-endorphin 
[15] anddynorphin(l-13) [16] will also form stable 
acetaldehyde adducts with concomitant changes in 
opiate activity. 
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